Sexual risk behaviour and viral suppression among HIV-infected adults receiving medical care in the United States

AIDS

Volumn 28, Issue 8, 2014, Pages 1203-1211

  Mattson, Christine L ^a   Freedman, Mark ^a   Fagan, Jennifer L ^a   Frazier, Emma L ^a   Beer, Linda ^a   Huang, Ping ^b   Valverde, Eduardo E ^a   Johnson, Christopher ^a   Sanders, Catherine ^a   McNaghten, A D ^c   Sullivan, Patrick ^c   Lansky, Amy ^a   Mermin, Jonathan ^a   Heffelfinger, James ^d   Skarbinski, Jacek ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ICF INTERNATIONAL   (United States)

^c EMORY UNIVERSITY   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antiretroviral therapy; HIV infected persons; Sexual behaviour; Unsafe sex; Viral load

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PRESCRIPTION DRUG; VIRUS RNA;

ADULT; ANAL INTERCOURSE; ANTIVIRAL THERAPY; ARTICLE; COITUS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTERVIEW; MALE; MEDICAL CARE; MEDICAL RECORD REVIEW; MIDDLE AGED; OUTPATIENT CARE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; SELF REPORT; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; TREATMENT RESPONSE; UNITED STATES; UNPROTECTED SEX; VIRUS LOAD; VIRUS TRANSMISSION; YOUNG ADULT; ADOLESCENT; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; OUTPATIENT; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PREVALENCE; RISK-TAKING; RNA, VIRAL; SELF REPORT; SEXUAL BEHAVIOR; UNITED STATES; VIRAL LOAD; YOUNG ADULT;

EID: 84910098053     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000273     Document Type: Article

References (40)

1. Centers for Disease Control and Prevention. Estimated HIV incidence in the United States, 2007-2010. HIV Surveillance Supplemental Report 2012. 2012; 17 (No. 4). http://www.cdc.gov/hiv/topics/surveillance/resources/reports/#supplemental. [Accessed 21 December 2012].
2. Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data: United States and 6 U.S. dependent areas - 2010. HIV Surveillance Supplemental Report. 2012. 17 (No. 3, part A). http://www.cdc.gov/hiv/topics/surveillance/resources/reports/.
3. Ciccarone DH, Kanouse DE, Collins RL, Chen JL, Morton SC, Stall R. Sex without disclosure of positive HIV serostatus in a US probability sample of persons receiving medical care for HIV infection. Am J Public Health 2003; 93:949-954.
4. Attia S, Egger M, Müller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and meta-analysis. AIDS 2009; 23:1397-1404.
5. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipou MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
6. Forsyth AD, Valdiserri RO. Reaping the prevention benefits of highly active antiretroviral treatment: policy implications of HIV Prevention Trials Network 052. Curr Opin HIV AIDS 2012; 7:111-116.
7. Garnett GP, Becker S, Bertozzi S. Treatment as prevention: Translating efficacy trial results to population effectiveness. Curr Opin HIV AIDS 2012; 7:157-163.
8. Heijman T, Geskus RB, Davidovich U, Coutinho RA, Prins M, Stolte IG. Less decrease in risk behaviour from pre-HIV to post-HIV seroconversion among MSM in the combination antiretroviral therapy era compared with the precombination antiretroviral therapy era. AIDS 2012; 26:489-495.
9. Mayer KH. Antiretrovirals for HIV prevention: Translating promise into praxis. Lancet 2011; 378:206-208.
10. Shelton JD. HIV/AIDS. ARVs as HIV prevention: A tough road to wide impact [Policy Forum]. Science 2011; 334:1645-1646.
11. Blower SM, Gershengorn HB, Grant RM. A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science 2000; 287:650-654.
12. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: A meta-analytic review. JAMA 2004; 292:224-236.
13. Katz MH, Schwarcz SK, Kellogg TA, Klausner JD, Dilley JW, Gibson S, et al. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health 2002; 92:388-394.
14. Crepaz N, Marks G, Liau A, Mullins MM, Aupont LW, Marshall KJ, et al. Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States: A metaanalysis. AIDS 2009; 23:1617-1629.
15. Centers for Disease Control and Prevention. Trends in primary and secondary syphilis in men who have sex with men: San Francisco and Los Angeles, California, 1998-2002. MMWR Morb Mortal Wkly Rep 2004; 53:575-578.
16. Frankel M, McNaghten A, Shapiro M, Sullivan PS, Berry SH, Johnson CH, et al. A probability sample for monitoring the HIV-infected population in care in the U.S. and in selected states. Open AIDS J 2012; 6 (Suppl 1):67-76.
17. The American Association for Public Opinion Research. 2011. Standard definitions: final dispositions of case codes and outcome rates for surveys. 7th ed. AAPOR. http://www.aapor.org/AM/Template.cfm?Section=Standard-Definitions2&Template=/CM/ContentDisplay.cfm&ContentID=3156.
18. Heeringa SG, West BT, Berglund PA. Applied survey data analysis. London: Chapman and Hall; 2010.
19. Särndal C-E, Lundström S. Estimation in surveys with nonresponse. Chichester: John Wiley & Sons; 2005.
20. Center for Disease Control and Prevention. Distinguishing public health research and public health nonresearch. 2010. http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-research-nonresearch.pdf. [Accessed 12 July 2013].
21. Protection of Human Subjects, US Federal Code Title 45 Part 46. 2009. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html. [Accessed 12 July 2013].
22. Rao JNK, Scott AJ. The analysis of categorical data from complex sample surveys: Chi-squared tests for goodness of fit and independence in two-way tables. J Am Stat Assoc 1981; 76:221-230.
23. Lohr SL. Sampling: Design and analysis. Duxbury Press, Imprint of Brooks/Cole Publishing Company, Pacific Grove, California; 1999.
24. Bieler GS, Brown GG, Williams RL, Brogan DJ. Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. Am J Epidemiol 2010; 171:618-623.
25. SAS Institute Inc. Base SAS 9.3 utilities: reference. Cary, NC: SAS Institute Inc; 2011.
26. SUDAAN 10.0.1. Research Triangle Park, NC: RTI International; 2009.
27. Weinhardt L, Kelly JA, Brondino M, Rotheram-Borus MJ, Kirshenbaum SB, Chesney MA, et al. HIV transmission risk behavior among men and women living with HIV in 4 cities in the United States. J Acquir Immune Defic Syndr 2004; 36:1057-1066.
28. HHS Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2012. http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf [Accessed 1 May 2013].
29. Golin C, Marks G, Wright J, Gerkovich Mary, Tien Hsiao-Chuan, Patel SN, et al. Psychosocial characteristics and sexual behaviors of people in care for HIV infection: An examination of men who have sex with men, heterosexual men and women. AIDS Behav 2009; 13:1129-1142.
30. Morin SF, Myers JJ, Shade SB, Koester K, Maiorana A, Rose CD. Predicting HIV transmission risk among HIV-infected patients seen in clinical settings. AIDS Behav 2007; 11 (Suppl 1):6-16.
31. Varghese B, Maher J, Peterman T, Branson B, Steketee R. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis 2002; 29:38-43.
32. Beyrer C, Sullivan PS, Sanchez J, Dowdy D, Altman D, Trapence G, et al. A call to action for comprehensive HIV services for men who have sex with men. Lancet 2012; 380:424-438.
33. Centers for Disease Control and Prevention. Vital signs: HIV prevention through care and treatment: United States. MMWR Morb Mortal Wkly Rep 2011; 60:1618-1623.
34. Hall HI, Frazier E, Rhodes P, Holtgrave DR, Furlow-Parmely C, Tang T, et al. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Intern Med 2013; 173:1337-1344.
35. Fisher JD, Fisher WA, Cornman DH, Amico KR, Bryan A, Friedland GH. Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients. J Acquir Immune Defic Syndr 2006; 41:44-52.
36. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2003; 52:1-24.
37. Flagg E. Syphilis testing among HIV-infected adults receiving medical care: National estimates from the Medical Monitoring Project, 2009 Data Collection Cycle. IDSA IDWeek 2012; 17- 21 October 2012; San Diego, CA.
38. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20:1447-1450.
39. Groves RM, Peytchiva E. The impact of nonresponse rates on nonresponse bias. Public Opin Q 2008; 72:167-189.
40. Schroder KE, Carey MP, Vanable PA. Methodological challenges in research on sexual risk behavior, II: Accuracy of self-reports. Ann Behav Med 2003; 26:104-123.